| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |